Voloridge Investment Management
BLUE

Voloridge Investment Management’s bluebird bio BLUE Stock Holding History

Voloridge Investment Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-52,612
Closed -$3.35M – 1363
2023
Q1 		$3.35M Sell
52,612
-9,427
-15% -$1.08M 0.02% 809
2022
Q4 		$8.59M Buy
62,039
+36,152
+140% +$5.09M 0.05% 471
2022
Q3 		$3.28M Sell
25,887
-2,287
-8% -$259K 0.02% 808
2022
Q2 		$2.33M Sell
28,174
-14,913
-35% -$1.16M 0.01% 965
2022
Q1 		$4.18M Buy
43,087
+34,063
+377% +$4.49M 0.02% 694
2021
Q4 		$1.8M Sell
9,024
-40,211
-82% -$9.49M 0.01% 1106
2021
Q3 		$12.2M Buy
49,235
+13,012
+36% +$3.72M 0.08% 363
2021
Q2 		$15M Sell
36,223
-4,274
-11% -$1.69M 0.1% 255
2021
Q1 		$15.8M Buy
40,497
+39,066
+2,730% +$19.2M 0.12% 234
2020
Q4 		$802K Buy
1,431
+836
+141% +$530K 0.01% 1028
2020
Q3 		$416K Buy
+595
New +$464K ﹤0.01% 1118
2020
Q1 		– Sell
-4,222
Closed -$4.8M – 1106
2019
Q4 		$4.8M Buy
+4,222
New +$4.59M 0.09% 276
2019
Q1 		– Sell
-4,254
Closed -$5.47M – 933
2018
Q4 		$5.47M Buy
+4,254
New +$6.53M 0.25% 109
2018
Q2 		– Sell
-1,065
Closed -$2.36M – 420
2018
Q1 		$2.36M Sell
1,065
-4,230
-80% -$10.8M 0.06% 267
2017
Q4 		$12.2M Sell
5,295
-4,214
-44% -$8.56M 0.27% 92
2017
Q3 		$16.9M Sell
9,509
-727
-7% -$1.02M 0.38% 60
2017
Q2 		$13.9M Buy
10,236
+4,279
+72% +$5.16M 0.35% 80
2017
Q1 		$7.01M Buy
5,957
+744
+14% +$759K 0.17% 151
2016
Q4 		$4.17M Buy
+5,213
New +$4.14M 0.09% 285
2015
Q4 		– Sell
-7,258
Closed -$8.04M – 193
2015
Q3 		$8.04M Sell
7,258
-732
-9% -$1.33M 0.38% 66
2015
Q2 		$17.4M Buy
7,990
+7,208
+922% +$14.7M 0.89% 27
2015
Q1 		$1.22M Buy
+782
New +$1.03M 0.06% 210

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Voloridge Investment Management's BLUE Position: Q2 2023 in Review

Voloridge Investment Management sold out of bluebird bio (BLUE) in Q2 2023, closing a stake of 52,612 shares — an estimated $3.35M sold.

Voloridge Investment Management first reported a position in BLUE in Q1 2015 and held it in 22 quarters. The position peaked at $17.4M in Q2 2015. 175 funds tracked by Wall St. Rank hold BLUE as of Q2 2023.

  • Voloridge Investment Management reported no remaining bluebird bio position as of Q2 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 52,612 bluebird bio shares in Q2 2023, an estimated $3.35M.
  • Voloridge Investment Management first reported a position in bluebird bio in Q1 2015 and held it in 22 quarters.
  • Voloridge Investment Management's bluebird bio position peaked at $17.4M in Q2 2015.
  • 175 funds tracked by Wall St. Rank held bluebird bio as of Q2 2023.

Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.